# Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery

> **NCT00874874** · PHASE2 · UNKNOWN · sponsor: **Centre Oscar Lambret** · enrollment: 96 (estimated)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** sorafenib tosylate

## Key facts

- **NCT ID:** NCT00874874
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-05
- **Primary completion:** 2011-05
- **Final completion:** —
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2009-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00874874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00874874, "Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00874874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*